OBD — Oxford Biodynamics Cashflow Statement
0.000.00%
Last trade - 00:00- £25.26m
- £26.45m
- £0.51m
Annual cashflow statement for Oxford Biodynamics, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.39 | -4.91 | -7.63 | -7.57 | -11.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.022 | 0.236 | 0.245 | -0.778 | 1.62 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.75 | 0.806 | 0.378 | 1.96 | 0.143 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.27 | -3.4 | -5.92 | -5.18 | -8.29 |
| Capital Expenditures | -0.632 | -0.457 | -3.09 | -0.901 | -0.716 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -10.6 | 5.04 | 5.92 | 2.15 | 0.096 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11.2 | 4.58 | 2.83 | 1.25 | -0.62 |
| Financing Cash Flow Items | 0 | — | — | -0.358 | -1.46 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.236 | -0.181 | -0.804 | 2.56 | 13.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.1 | 0.921 | -3.94 | -1.2 | 4.28 |